Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Harvard Business School
Mallinckrodt
McKinsey
AstraZeneca

Last Updated: May 21, 2022

Drug Sales Trends for ENBREL SRCLK


✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ENBREL SRCLK (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $290,344,936
INSIDE ANOTHER STORE $313,153,810
[disabled in preview] $1,132,814,203
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 56,856
INSIDE ANOTHER STORE 63,677
[disabled in preview] 227,450
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $103,195,986
MEDICARE $1,159,702,989
[disabled in preview] $473,413,974
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ENBREL SRCLK
Drug Units Sold Trends for ENBREL SRCLK

Annual Sales Revenues and Units Sold for ENBREL SRCLK

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ENBREL SRCLK See Plans and Pricing See Plans and Pricing 2019
ENBREL SRCLK See Plans and Pricing See Plans and Pricing 2018
ENBREL SRCLK See Plans and Pricing See Plans and Pricing 2017
ENBREL SRCLK See Plans and Pricing See Plans and Pricing 2016
ENBREL SRCLK See Plans and Pricing See Plans and Pricing 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Colorcon
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.